Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the The Introduction of Dendrimers As a New Approach to Improve the Performance and Quality of Various Blood Products (Platelets, Plasma and Erythrocytes): A 2010-2022 Review Study
Fatemeh Nabavizadeh Rafsanjani
Fatemeh Nabavizadeh Rafsanjani

Professor of Physiology

Department Physiology

School of Medicine

Electrophysiology Research Center

Tehran University of Medical Sciences

All Documents
1. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
2. Can Infliximab Serve As a New Therapy for Neuropsychiatric Symptoms?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)